180 Life Sciences EV/EBIT
Qual é o EV/EBIT de 180 Life Sciences?
O EV/EBIT de 180 Life Sciences Corp. é N/A
Qual é a definição de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de empresas na Setor Health Care em NASDAQ em comparação com 180 Life Sciences
O que 180 Life Sciences faz?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Empresas com ev/ebit semelhantes a 180 Life Sciences
- Asensus Surgical Inc tem EV/EBIT de N/A
- Aurelius Minerals tem EV/EBIT de N/A
- Pintec Technology Ltd tem EV/EBIT de N/A
- Spherix tem EV/EBIT de N/A
- DiscovEx Resources tem EV/EBIT de N/A
- Superconductor Technologies tem EV/EBIT de N/A
- 180 Life Sciences tem EV/EBIT de N/A
- Westar Resources tem EV/EBIT de N/A
- Chaparral tem EV/EBIT de N/A
- Katoro Gold plc tem EV/EBIT de N/A
- Synairgen plc tem EV/EBIT de N/A
- Graycliff Exploration tem EV/EBIT de N/A
- DBV Technologies tem EV/EBIT de N/A